Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Experimental & Clinical Cancer Research : CR|December 18, 2019
Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpressionS Napolitano, N Matrone, A L Muddassir, et al.
Current Oncology (Toronto, Ont.)|August 2, 2013
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancerF Morgillo, F De Vita, G Antoniol, et al.
British Journal of Cancer|May 10, 2012
Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cellsT Troiani, L Vecchione, E Martinelli, et al.
Gastroenterology Research and Practice|July 10, 2018
Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score AnalysisJ Ventriglia, A Petrillo, M Huerta Alváro, et al.
Cancer Investigation|March 5, 2008
Serum vascular endothelial growth factor (VEGF) levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancerF Iovino, F Ferraraccio, M Orditura, et al.
Breast (Edinburgh, Scotland)|August 14, 2018
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugsM Orditura, C M Della Corte, A Diana, et al.
British Journal of Cancer|January 20, 2011
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancerF De Vita, M Orditura, E Martinelli, et al.
Current Oncology (Toronto, Ont.)|June 19, 2014
Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma-a pilot studyM Orditura, G Galizia, N Di Martino, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Off-label drug use in oncology: integrating molecular and genetic analysis in an academic center's real-world approachE Cioli, G Suarato, R Napolitano, et al.
Lung Cancer (Amsterdam, Netherlands)|July 1, 2025
Predictive role of functional respiratory tests in LUng toxicity in stage III NSCLC treated with chemo-, raDIO- and immuno-therapy: PRELUDIO TRIALP M Medusa, N Carro, F Morgillo, et al.
Pageof 3